Cargando…

A novel statistical approach for identification of the master regulator transcription factor

BACKGROUND: Transcription factors are known to play key roles in carcinogenesis and therefore, are gaining popularity as potential therapeutic targets in drug development. A ‘master regulator’ transcription factor often appears to control most of the regulatory activities of the other transcription...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikdar, Sinjini, Datta, Susmita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288875/
https://www.ncbi.nlm.nih.gov/pubmed/28148240
http://dx.doi.org/10.1186/s12859-017-1499-x
_version_ 1782504408050827264
author Sikdar, Sinjini
Datta, Susmita
author_facet Sikdar, Sinjini
Datta, Susmita
author_sort Sikdar, Sinjini
collection PubMed
description BACKGROUND: Transcription factors are known to play key roles in carcinogenesis and therefore, are gaining popularity as potential therapeutic targets in drug development. A ‘master regulator’ transcription factor often appears to control most of the regulatory activities of the other transcription factors and the associated genes. This ‘master regulator’ transcription factor is at the top of the hierarchy of the transcriptomic regulation. Therefore, it is important to identify and target the master regulator transcription factor for proper understanding of the associated disease process and identifying the best therapeutic option. METHODS: We present a novel two-step computational approach for identification of master regulator transcription factor in a genome. At the first step of our method we test whether there exists any master regulator transcription factor in the system. We evaluate the concordance of two ranked lists of transcription factors using a statistical measure. In case the concordance measure is statistically significant, we conclude that there is a master regulator. At the second step, our method identifies the master regulator transcription factor, if there exists one. RESULTS: In the simulation scenario, our method performs reasonably well in validating the existence of a master regulator when the number of subjects in each treatment group is reasonably large. In application to two real datasets, our method ensures the existence of master regulators and identifies biologically meaningful master regulators. An R code for implementing our method in a sample test data can be found in http://www.somnathdatta.org/software. CONCLUSION: We have developed a screening method of identifying the ‘master regulator’ transcription factor just using only the gene expression data. Understanding the regulatory structure and finding the master regulator help narrowing the search space for identifying biomarkers for complex diseases such as cancer. In addition to identifying the master regulator our method provides an overview of the regulatory structure of the transcription factors which control the global gene expression profiles and consequently the cell functioning. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12859-017-1499-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5288875
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52888752017-02-06 A novel statistical approach for identification of the master regulator transcription factor Sikdar, Sinjini Datta, Susmita BMC Bioinformatics Methodology Article BACKGROUND: Transcription factors are known to play key roles in carcinogenesis and therefore, are gaining popularity as potential therapeutic targets in drug development. A ‘master regulator’ transcription factor often appears to control most of the regulatory activities of the other transcription factors and the associated genes. This ‘master regulator’ transcription factor is at the top of the hierarchy of the transcriptomic regulation. Therefore, it is important to identify and target the master regulator transcription factor for proper understanding of the associated disease process and identifying the best therapeutic option. METHODS: We present a novel two-step computational approach for identification of master regulator transcription factor in a genome. At the first step of our method we test whether there exists any master regulator transcription factor in the system. We evaluate the concordance of two ranked lists of transcription factors using a statistical measure. In case the concordance measure is statistically significant, we conclude that there is a master regulator. At the second step, our method identifies the master regulator transcription factor, if there exists one. RESULTS: In the simulation scenario, our method performs reasonably well in validating the existence of a master regulator when the number of subjects in each treatment group is reasonably large. In application to two real datasets, our method ensures the existence of master regulators and identifies biologically meaningful master regulators. An R code for implementing our method in a sample test data can be found in http://www.somnathdatta.org/software. CONCLUSION: We have developed a screening method of identifying the ‘master regulator’ transcription factor just using only the gene expression data. Understanding the regulatory structure and finding the master regulator help narrowing the search space for identifying biomarkers for complex diseases such as cancer. In addition to identifying the master regulator our method provides an overview of the regulatory structure of the transcription factors which control the global gene expression profiles and consequently the cell functioning. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12859-017-1499-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-02 /pmc/articles/PMC5288875/ /pubmed/28148240 http://dx.doi.org/10.1186/s12859-017-1499-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Sikdar, Sinjini
Datta, Susmita
A novel statistical approach for identification of the master regulator transcription factor
title A novel statistical approach for identification of the master regulator transcription factor
title_full A novel statistical approach for identification of the master regulator transcription factor
title_fullStr A novel statistical approach for identification of the master regulator transcription factor
title_full_unstemmed A novel statistical approach for identification of the master regulator transcription factor
title_short A novel statistical approach for identification of the master regulator transcription factor
title_sort novel statistical approach for identification of the master regulator transcription factor
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288875/
https://www.ncbi.nlm.nih.gov/pubmed/28148240
http://dx.doi.org/10.1186/s12859-017-1499-x
work_keys_str_mv AT sikdarsinjini anovelstatisticalapproachforidentificationofthemasterregulatortranscriptionfactor
AT dattasusmita anovelstatisticalapproachforidentificationofthemasterregulatortranscriptionfactor
AT sikdarsinjini novelstatisticalapproachforidentificationofthemasterregulatortranscriptionfactor
AT dattasusmita novelstatisticalapproachforidentificationofthemasterregulatortranscriptionfactor